EUVIMEDSkopri EUVIMED
Crossref

Inhibition of Adenosine Triphosphate Production in Pancreatic Cancer Cells by a Library of N‐(1H‐Indol‐4‐ylmethyl)benzenesulfonamide and N‐(1H‐Indol‐5‐ylmethyl)benzenesulfonamide Analogs

Ryan C Witt, Caroline E Dunn, Levi A Zanders, Adeleye A Edema, Sakariyau A Waheed, Carina A Derewonko, Lauren C Franzen, Presley L Osborn, Jenna D Caudle, Robert J Sheaff, Angus A Lamar iD

ChemMedChem · 2025

DOI: 10.1002/cmdc.202500136 ↗

At a glance

Journal article in ChemMedChem, 2025. Written by Ryan C Witt and 10 co-authors. Institution: Department of Chemistry and Biochemistry, The University of Tulsa, 800 South Tucker Drive, Tulsa, OK, 74104, USA. Major MEDLINE topics: Sulfonamides, Pancreatic Neoplasms, Adenosine Triphosphate, Antineoplastic Agents. 50 references. Funded by: Oklahoma Center for the Advancement of Science and Technology.

AstrattSubjectsDettalji biblijografiċiCiteRelated studies

Abstract (original language)

A library of 50 indolyl sulfonamides and 9 amide analogs based upon the 4‐indolyl and 5‐indolyl frameworks has been synthesized to target the metabolic processes of pancreatic cancer. Thirteen of the 50 compounds are identified as cytotoxic at 50 μM using a traditional (48‐h compound exposure) assay against 7 pancreatic cancer cell lines and 1 noncancerous cell line. The potential role of the compounds as metabolic inhibitors of adenosine triphosphate (ATP) production is then evaluated using a rapid screening (1–2 h compound exposure) assay developed within our laboratories. The rapid assay identifies ten compounds as strong or moderate hits at 3 μM against the panel of pancreatic and noncancerous cell lines. The IC 50 values of the active compounds are determined using the rapid assay in the absence of glucose and four of the compounds display an IC 50 value

Subjects

MeSH terms (MEDLINE)

SulfonamidesPancreatic NeoplasmsAdenosine TriphosphateAntineoplastic AgentsIndolesSmall Molecule LibrariesHumansDrug Screening Assays, AntitumorStructure-Activity RelationshipCell Line, TumorMolecular StructureDose-Response Relationship, DrugCell Proliferation

Author keywords

chemotherapy resistancesindolesoxidative phosphorylation inhibitorspancreatic cancers

Substances

SulfonamidesAdenosine TriphosphateAntineoplastic AgentsIndolesSmall Molecule Libraries

Authors and institutions

  • Department of Chemistry and Biochemistry, The University of Tulsa, 800 South Tucker Drive, Tulsa, OK, 74104, USA.

ORCID profiles: Angus A Lamar

Funding

  • Oklahoma Center for the Advancement of Science and Technology

Cite

APA

Witt, R. C., Dunn, C. E., Zanders, L. A., Edema, A. A., Waheed, S. A., Derewonko, C. A., Franzen, L. C., Osborn, P. L., Caudle, J. D., Sheaff, R. J., & Lamar, A. A. (2025). Inhibition of Adenosine Triphosphate Production in Pancreatic Cancer Cells by a Library of N‐(1H‐Indol‐4‐ylmethyl)benzenesulfonamide and N‐(1H‐Indol‐5‐ylmethyl)benzenesulfonamide Analogs. ChemMedChem. https://doi.org/10.1002/cmdc.202500136

Vancouver

Witt RC, Dunn CE, Zanders LA, Edema AA, Waheed SA, Derewonko CA, et al. Inhibition of Adenosine Triphosphate Production in Pancreatic Cancer Cells by a Library of N‐(1H‐Indol‐4‐ylmethyl)benzenesulfonamide and N‐(1H‐Indol‐5‐ylmethyl)benzenesulfonamide Analogs. ChemMedChem. 2025. doi:10.1002/cmdc.202500136

BibTeX
@article{Witt2025,
  author = {Witt, Ryan C and Dunn, Caroline E and Zanders, Levi A and Edema, Adeleye A and Waheed, Sakariyau A and Derewonko, Carina A and Franzen, Lauren C and Osborn, Presley L and Caudle, Jenna D and Sheaff, Robert J and Lamar, Angus A},
  title = {Inhibition of Adenosine Triphosphate Production in Pancreatic Cancer Cells by a Library of N‐(1H‐Indol‐4‐ylmethyl)benzenesulfonamide and N‐(1H‐Indol‐5‐ylmethyl)benzenesulfonamide Analogs},
  journal = {ChemMedChem},
  year = {2025},
  doi = {10.1002/cmdc.202500136}
}
Start for free →